#Healthcare Policy
Total 10 articles
As US officials move to restrict pharmaceutical advertising, new research reveals the complex tradeoffs between consumer choice and medical oversight in America's unique drug marketing landscape.
Trump's TrumpRx policy launches with experts predicting limited reach beyond weight-loss medications. Analysis of the reality and constraints of prescription drug price reduction efforts.
The US government has reversed $2 billion in cuts to mental health and addiction programs following bipartisan backlash. Learn more about the funding restoration.
PRISM by Liabooks
Place your ad in this space
[email protected]
The US House prepares to vote on a 3-year ACA subsidy extension as a bipartisan Senate group nears a potential deal. Discover how this impact the 2026 healthcare landscape.
A U.S. court has blocked the Trump administration's drug rebate pilot program as of January 8, 2026. Read about the legal challenges and market impact on PBMs.
Senator Peter Welch suggests a retroactive ACA subsidy extension is possible in 2026 but requires President Trump's support. Read the full analysis.
Explore the impact of the ACA healthcare subsidies expiration 2026 as 22 million Americans face soaring premiums and a shifting political landscape.
PRISM by Liabooks
Place your ad in this space
[email protected]
Japan's government has approved a 2.22% hike in medical fees and a 2.03% rise in nursing care costs to manage its aging society. This move clashes with a local proposal to halt hiring foreign workers, revealing a deep policy contradiction.
The Biden administration announced a massive expansion of the Medicare drug price negotiation program from 10 to 50 drugs, sparking a sell-off in pharma stocks and a legal threat from the industry.
President Biden's plan to ban medical debt from credit reports is a major pre-election move. PRISM analyzes its impact on fintech, lending, and global business.
